Epstein-Barr virus in Hodgkin's disease

Annals of Oncology

Volumn 9, Issue SUPPL. 5, 1998, Pages

  Chapman, A L N ^a   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Burkitt's lymphoma; Cytotoxic T lymphocyte response; Epstein Barr virus; Hodgkin's disease; Immunotherapy; Post transplant lymphoproliferative disease; Viral pathogenesis

Indexed keywords

VIRUS ANTIGEN;

ANTIGEN EXPRESSION; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0032447969     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_5.S5     Document Type: Conference Paper

References (11)

1. Kanzler H, Kuppers R, Hansmann M et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Mod 1996; 184: 1495-505.
2. Gerber P, Nonoyama M, Lucas S, Perlin E, Goldstein LI. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 1972; 2: 988-9.
3. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the inlerindividual infection route of Epstein-Barr virus. Blood 1995; 85: 744-50.
4. Rickinson AB, Epstein MA, Crawford DH. Absence of infectious Epstein-Barr virus in blood in acute infectious mononucleosis. Nature 1975; 258: 236-8.
5. Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV. Int J Cancer 1971; 8: 443-50.
6. Tiernay RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994; 68: 7374-85.
7. Kerr BM, Lear AL, Rowe M et al. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 1992; 187: 189-201.
8. rd edition. Philadephia: Lippincott-Raven Publishers 1996.
9. Henkel T, Ling PD, Hayward SD, Peterson MG. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 1994; 265: 92-5.
10. Woisetschlaeger M, Strominger JL, Speck SH. Mutually exclusive use of viral promoters in EBV latently infected lymphocytes. Proc Natl Acad Sci USA 1989; 86: 6498-502.
11. Woisetschlaeger M, Yandava CN, Furmanski LA et al. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci USA 1990; 87: 1725-9.